Literature DB >> 2404442

Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus.

Y Majima1, K Hirata, K Takeuchi, M Hattori, Y Sakakura.   

Abstract

The effects of orally administered drugs on rheologic properties of nasal mucus were investigated in adult chronic sinusitis patients. The elastic modulus G' and the dynamic viscosity eta' of nasal mucus were determined by an oscillating sphere magnetic rheometer. Both G' and eta' values of the mucus before drug administration were much higher than optimal viscoelasticity for mucociliary transport. Norfloxacin, an antibacterial agent, reduced the G' but not the eta' of nasal mucus. Serratiopeptidase, a proteolytic enzyme, reduced eta' but did not reduce G'. S-carboxymethylcysteine, a blocked thiol derivative of cysteine, did not change either G' or eta'. L-cysteine ethyl ester hydrochloride, a sulfhydryl type of agent, reduced both G' and eta'. The results indicate that some of the orally administered mucokinetic agents can improve the abnormal rheologic properties of nasal mucus in chronic sinusitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404442     DOI: 10.1164/ajrccm/141.1.79

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  A technique for quantitative cytology of nasal secretions.

Authors:  H S Lee; Y Majima; Y Sakakura; B W Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

2.  Viscoelastic properties of bioadhesive, chlorhexidine-containing semi-solids for topical application to the oropharynx.

Authors:  D S Jones; A D Woolfson; A F Brown
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.

Authors:  Manju Rawat; Shailendra Saraf; Swarnlata Saraf
Journal:  AAPS PharmSciTech       Date:  2007-12-28       Impact factor: 3.246

Review 4.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

5.  Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.

Authors:  Charu Sharma; Niraj Kumar Jha; M F Nagoor Meeran; Chandragouda R Patil; Sameer N Goyal; Shreesh Ojha
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

6.  Apremilast mitigates interleukin (IL)-13-induced inflammatory response and mucin production in human nasal epithelial cells (hNECs).

Authors:  Jia Liang; RuoXiao Zhuang; XueYao Sun; Feng Zhang; Bin Zou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.